|
|
'The Charlatan' rose Description
Photo courtesy of Rosen-Shop.de
HMF Ratings:
105 favorite votes.
Average rating:
EXCELLENT-.
ARS:
Light pink Shrub. Registration name: MeiguimovExhibition name: The Charlatan
Bloom:
Blush to white, red stamens. None / no fragrance. 5 petals. Average diameter 2". Medium, single (4-8 petals), in large clusters, cupped-to-flat bloom form. Prolific, continuous (perpetual) bloom throughout the season. Small, pointed buds.
Habit:
Medium, bushy, rounded. Glossy, dark green, dense foliage. 3 to 7 leaflets.
Height: 2' to 3' (60 to 90cm). Width: up to 4' (up to 120cm).
Growing:
USDA zone 6b through 9b (default). Can be used for garden, ground cover or pillar. Disease susceptibility: disease resistant, very mildew resistant, very rust resistant.
Breeder's notes:
It is highly unusual that a single flower with only five petals leaves such a lasting impression to everyone who sees it for the first time. This truly unique rose, always in bloom, showcases its golden stamens as very few other roses do. A multiple Gold winner awards over the last couple of years, its uniqueness makes it the natural follow up to The Imposter in the highly popular Garden Compass program. This rose may need pruning from time to time as it has the tendency to get wild once in a while, or can be trained as a small climber.
Patents:
United States - Patent No: PP 18,990 on 24 Jun 2008 VIEW USPTO PATENTApplication No: 11/518,913 on 12 Sep 2006 Inventors: Meilland; Alain A. (Antibes, FR)
The female parent (i.e., the seed parent) was the product of the cross of the `Meidomonac` variety (U.S. Plant Pat. No. 5,105) and the `Playboy` variety (non-patented in the United States). The male parent (i.e., the pollen parent) was the `Meinoiral` variety (non-patented in the United States).....The description is based on the observation of two-year-old plants during June
Notes:
Meilland Collection 2006. Pink Stamens
ARS Classification: Shrub (groundcover), patent application classification: Floribunda
Ploidy information supplied by David Zlesak.
|
